The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,969,307 in first-year total cost, median $387,917.
Most frequent study sections
- Special Emphasis Panel[ZAR1 XZ (M1)]5
Most frequent institutions
- PENNSYLVANIA STATE UNIV HERSHEY MED CTR1
- UNIV OF MASSACHUSETTS MED SCH WORCESTER1
- UNIVERSITY OF CALIFORNIA, SAN DIEGO1
- UNIVERSITY OF MICHIGAN AT ANN ARBOR1
- YALE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Dissecting autoimmune cellular and molecular networks in vitiligo1R61AR073042-01 | GARBER, MANUELHARRIS, JOHN E | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $418,750 | ZAR1 |
| 2017 | An in vivo CRISPR-Cas9 genetic screen in murine primary T cells to discover metabolic regulators of follicular B helper T (Tfh) cell differentiation1R61AR073048-01 | CRAFT, JOSEPH EDGARFLAVELL, RICHARD A | YALE UNIVERSITY, CT | $395,514 | ZAR1 |
| 2017 | Empirical validation of a novel HLA-disease association theory in skin and rheumatic diseases1R61AR073014-01 | HOLOSHITZ, JOSEPH | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $387,917 | ZAR1 |
| 2017 | Enhancement of wound healing and regeneration through heparan sulfate deficiency1R61AR073031-01 | ESKO, JEFFREY D | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $384,245 | ZAR1 |
| 2017 | Mesenchymal Stem Cells Derived from Human Gingiva (GMSC) Inhibit Bone Erosion in Autoimmune Arthritis1R61AR073049-01 | ZHENG, SONG GUO | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $382,881 | ZAR1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.